Skip to main content
Clinical Trials/NCT00476372
NCT00476372
Completed
Not Applicable

Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms -the Relation Between Cognitive Deficits and Comorbid Psychiatric Disorders, Medication, and Age at Disease Onset

University of Aarhus1 site in 1 country107 target enrollmentAugust 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
University of Aarhus
Enrollment
107
Locations
1
Primary Endpoint
cognitive measures
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Background: Approximately 40% of patients with Parkinson's disease (PD) have cognitive impairments. There is a lack of consensus as to the extent to which psychiatric symptoms, depression, age at disease onset, disease duration, and medication is related to the type and severity of cognitive impairment. This discrepancy can in part be caused by the lack of distinction between patients with different motor symptoms and disease severity.

Objective: To identify the extent to which psychiatric symptoms, depression, age at disease onset, disease duration, and medication is related to the severity and type of cognitive dysfunction in patients with idiopathic PD categorized according to motor symptoms and disease severity.

Methods: the population of patients with PD in the old county of Aarhus is described on the background of medical records, and stratified in accordance to age, sex and cardinal symptoms. Through proportional allocation a sample of a minimum of 50 patients with PD is drawn from the population. The patients and 30 healthy matched controls will undergo comprehensive neuropsychological assessment including tests of language, memory, executive function, and visuospatial function. Furthermore, all participants will be screened for depression (Geriatric Depression Scale) and psychiatric symptoms (Neuropsychiatric Inventory and Symptom Checklist). The patients will be categorized in accordance with their motor symptoms via cluster analysis for the purpose of analyzing the effect of psychiatric symptoms, depression, and age of disease onset, disease duration, and medication on cognition.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
December 2011
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Idiopathic Parkinson's in accordance to UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria,
  • Born and raised in Denmark ,
  • \>50 years

Exclusion Criteria

  • Cerebrovascular disease,
  • Dementia not caused by Parkinson's Disease,
  • Metabolism anomaly,
  • Abuse of drugs, medication or alcohol,
  • History of head injuries,
  • Severe psychiatric disorder, excluding depression,
  • Resident outside the region of Aarhus h) DBS -

Outcomes

Primary Outcomes

cognitive measures

Time Frame: 1 hour

Study Sites (1)

Loading locations...

Similar Trials